Novo Hands Over Parkinson’s Therapy to Zuckerberg-Backed Startup
AI Summary
Novo has handed over its Parkinson's therapy to a startup backed by Mark Zuckerberg, indicating a strategic move in the biopharmaceutical industry. This collaboration potentially heralds advancements in treatment options for patients.